|
Product
Information
Treatment of
leg and foot ulcers is complex and often depends on the underlying cause of the
ulceration. A huge variety of dressings and other medications are available for
use with few having proven advantages over the others, which often results in
prescribing confusion. In fact, many dressings hold exudate against the wound,
allowing inhibitory proteins to slow down the formation of new granulation tissue
and thus inhibit healing. Therefore, despite the vast range of treatments there
is still a large unmet need for effective treatment options in this
therapeutic
area.
Kerraboot is a unique dressing device, available through UK hospitals
since November 2003 and listed on the Drug Tariff since 2004, for the management
of foot and leg ulcers. Kerraboot’s design is firmly based on the sound principles
of moist wound healing and addresses the limitations of current treatments. Its
unique dual-action ensures that exudate is removed from the wound whilst a warm
moist environment is maintained to facilitate healing. Kerraboot rationalises
prescribing choice in ulcer management, as there is no need for other dressings.
The
aims of Kerraboot are to remove the barriers to healing and aid patients by making
dressing changes more comfortable and by reducing odour. In addition, Kerraboot
aids nurses both in hospital and in the community by reducing time spent on dressings
and by simplifying treatment choice (4).
|
|
|
 |
How to order
Kerraboot is available on prescription and listed in the Drug Tarriff part IXA.
......read
more
|
Usage
Guidelines
Full instructions on how to correctly
apply Kerraboot and how often it should be changed as well as a detailed application
protocol. ......read more
|
|
|
